Understanding certification requirements is critical for contact lens brand owners. FDA (US) and CE (Europe) are the two most important certifications, and each has specific requirements.

FDA Certification (United States)

What is FDA?

The US Food and Drug Administration regulates contact lenses as medical devices. All contact lenses sold in the US must have FDA 510(k) clearance.

FDA Requirements

  • 510(k) premarket notification
  • Facility registration
  • Device listing
  • Quality system regulation (21 CFR Part 820)
  • Medical device reporting

FDA Timeline

Initial clearance: 3-6 months | Renewal: Annual

CE Certification (European Union)

What is CE?

CE marking indicates compliance with EU health, safety, and environmental requirements. Contact lenses fall under Medical Device Regulation (MDR).

CE Requirements

  • Technical documentation
  • Clinical evaluation
  • Quality management system (ISO 13485)
  • Notified Body assessment
  • Post-market surveillance

CE Timeline

Initial certification: 6-12 months | Renewal: Every 5 years

Key Differences

FDA vs CE Comparison

  • Market coverage: FDA = US only | CE = 30+ European countries
  • Process: FDA = product-specific | CE = system-based
  • Timeline: FDA = faster initial | CE = longer but broader
  • Cost: FDA = $3,000-15,000 | CE = €15,000-50,000+

Which Do You Need?

Choose FDA if:

  • Targeting US market primarily
  • Want faster initial clearance
  • Have limited budget for certification

Choose CE if:

  • Targeting European market
  • Want broader geographic coverage
  • Planning long-term international expansion

Ideal Scenario

Obtain both FDA and CE certifications. This gives you access to the two largest contact lens markets and demonstrates commitment to quality and safety.

At MIOMI Optical

We maintain both FDA and CE certifications:

  • FDA registered facility
  • CE marked products (MDR compliant)
  • ISO 13485 certified quality system
  • Full documentation support for brand registration

Contact us: eye@miomi.cc | miomicon.com

Receive the latest news in your email
Table of content
Related articles